Imbria Reports Positive Topline Results for Investigational New Drug Ninerafaxstat in Patients with Non-obstructive Hypertrophic Cardiomyopathy
07 nov. 2023 08h00 HE
|
Imbria Pharmaceuticals Inc.
– The IMPROVE-HCM Phase 2 clinical trial met the primary endpoint of safety and tolerability; 12-weeks treatment with ninerafaxstat also demonstrated a statistically significant improvement, compared...
Society of Plastics Engineers Names Associated Packaging Technologies a 2010 Environmental Stewardship Award Winner
01 mars 2010 17h20 HE
|
Associated Packaging Technologies
CHADDS FORD, PA--(Marketwire - March 1, 2010) - The Society of Plastics Engineers (SPE) has named Associated Packaging Technologies (APT), the Chadds Ford, PA-based maker of CPET and...